RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NWBO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Northwest Biotherapeutics stock price on Wednesday which ended trading at $0.600
(Updated on Mar 27, 2024)

Hold candidate since Mar 27, 2024 PDF

The Northwest Biotherapeutics stock price gained 12.99% on the last trading day (Wednesday, 27th Mar 2024), rising from $0.531 to $0.600. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 27.21% from a day low at $0.510 to a day high of $0.649. The price has fallen in 6 of the last 10 days but is still up by 10.09% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $2.38 million.

Given the current short-term trend, the stock is expected to fall -20.31% during the next 3 months and, with a 90% probability hold a price between $0.379 and $0.478 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NWBO Signals & Forecast

The Northwest Biotherapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.515 and $0.552. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, March 22, 2024, and so far it has risen 24.21%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Northwest Biotherapeutics stock

Northwest Biotherapeutics finds support from accumulated volume at $0.597 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.139 between high and low, or 27.21%. For the last week, the stock has had daily average volatility of 9.95%.

Our recommended stop-loss: $0.577 (-3.88%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (NWBO) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Northwest Biotherapeutics to open at $0.586, and during the day (based on 14 day Average True Range), to move between $0.560 and $0.640, which gives a possible trading interval of +/-$0.0404 (+/-6.73%) up or down from last closing price. If Northwest Biotherapeutics takes out the full calculated possible swing range there will be an estimated 13.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.597 (0.50%) than the resistance at $0.650 (8.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Northwest Biotherapeutics stock A Buy?

Northwest Biotherapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Northwest Biotherapeutics of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.586 ( 2.28%) $0.600

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NWBO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.725 20.86 %
R2 0.672 12.02 %
R1 0.639 6.56 %
Current price: 0.600
Support S1 0.533 -11.11 %
S2 0.501 -16.57 %
S3 0.448 -25.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.701 16.83 %
R2 0.670 11.67 %
R1 0.650 8.30 %
Current price 0.600
Support S1 0.597 -0.500%
S2 0.572 -4.75%
S3 0.550 -8.33%

FAQ

What is the symbol for Northwest Biotherapeutics Stock and on which exchange is it traded?
The symbol for Northwest Biotherapeutics is NWBO and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Northwest Biotherapeutics Stock?
Northwest Biotherapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Northwest Biotherapeutics Stock?
Northwest Biotherapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Northwest Biotherapeutics Stock.

What's the current price of Northwest Biotherapeutics Stock?
As of the end of day on the 2024-03-27, the price of an Northwest Biotherapeutics (NWBO) share was $0.600.

What is the 52-week high and low for Northwest Biotherapeutics Stock?
The 52-week high for Northwest Biotherapeutics Stock is $1.09 and the 52-week low is $0.400.

What is the market capitalization of Northwest Biotherapeutics Stock?
As of the 2024-03-27, the market capitalization of Northwest Biotherapeutics is 631.874M.

When is the next earnings date for Northwest Biotherapeutics?
The upcoming earnings date for Northwest Biotherapeutics is May 08, 2024.
Click to get the best stock tips daily for free!

About Northwest Biotherapeutics

Northwest Biotherapeutics Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company ... NWBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT